Revealing alcohol abuse: To ask or to test?

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 7, 2005, Pages 1257-1263

  Alling, C ^a   Chick, J D ^b   Anton, R ^c   Mayfield, R D ^d   Salaspuro, M ^e   Helander, A ^f   Harris, R Adron ^d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e UNIVERSITY OF HELSINKI   (Finland)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alcohol Abuse; Alcoholism; Biomarker; Genomic; Proteomic

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHOL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME;

ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; BLOOD SAMPLING; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA MICROARRAY; DRUNKEN DRIVING; GENOMICS; HUMAN; MEDICAL RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; PROTEOMICS; QUESTIONNAIRE; RELIABILITY; SCREENING TEST; SELF MONITORING;

ACCIDENTS, TRAFFIC; ALCOHOLIC INTOXICATION; ALCOHOLISM; BIOLOGICAL MARKERS; EUROPE; GENOMICS; HUMANS; MASS SCREENING; PROTEOMICS; SELF DISCLOSURE; SENSITIVITY AND SPECIFICITY; TRANSFERRIN; TREATMENT OUTCOME;

EID: 23044500302     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000171489.55856.A5     Document Type: Conference Paper

References (47)

1. Aertgeerts B, Buntinx F, Ansoms S, Fevery J (2001) Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population. Br J Gen Pract 51:206-217.
2. Allen JP, Litten RZ, Strid N, Sillanaukee P (2001) The role of biomarkers in alcoholism medication trials. Alcohol Clin Exp Res 25:1119-1125.
3. Alte D, Luedemann J, Rose HJ, John U (2004) Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP). Alcohol Clin Exp Res 28:931-940.
4. Anton RF, Lieber C, Tabakoff B (2002) Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 26:1215-1222.
5. Anton RF, Moak DH (1994) Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res 18:747-754.
6. Anton RF, Moak D, Latham P (2005) Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol (in press).
7. Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S (2004) A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol 24:421-428.
8. Beck O, Helander A (2003) 5-Hydroxytryptophol as a marker for recent alcohol intake. Addiction 98(Suppl 2):63-72.
9. Berg W, Linder C, Eschholz G, Link S, Schubert J (1999) Possibility of improving the acceptance rate of early detection testing for prostate cancer with a one-step test for prostate-specific antigen in whole blood. Urol Int 63:102-106.
10. Bueno R, Loughlin KR, Powell MH, Gordon GJ (2004) A diagnostic test for prostate cancer from gene expression profiling data. J Urol 171:903-906.
11. Daniels GM, Buck KJ (2002) Expression profiling identifies strain-specific changes associated with ethanol withdrawal in mice. Genes Brain Behav 1:35-45.
12. Geschwind DH (2003) DNA microarrays: translation of the genome from laboratory to clinic. Lancet Neurol 2:275-282.
13. Grammatopoulos D, Elliott Y, Smith SC, Brown I, Grieve RJ, Hillhouse EW, Levine MA, Ringel MD (2003) Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer. Mol Pathol 56:162-166.
14. Hassan S, Duong B, Kim KS, Miles MF (2003) Pharmacogenomic analysis of mechanisms mediating ethanol regulation of dopamine beta-hydroxylase. J Biol Chem 278:38860-38869.
15. Helander A (2001) Biological markers of alcohol use and abuse in theory and practice. In: Alcohol in Health and Disease (Agarwal D, Seitz H, eds). Marcel Dekker, New York, NY.
16. Helander A, Beck O (2004) Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin Chem 50:936-937.
17. Helander A, von Wachenfeldt J, Hiltunen A, Beck O, Liljeberg P, Borg S (1999) Comparison of urinary 5-hydroxytryptophol, breath ethanol, and self-report for detection of recent alcohol use during outpatient treatment: a study on methadone patients. Drug Alcohol Depend 56:33-38.
18. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677-1685.
19. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA 284:963-971.
20. Keso L, Salaspuro M (1990b) Inpatient treatment of employed alcoholics: a randomized clinical trial on Hazelden-type and traditional treatment. Alcohol Clin Exp Res 14:584-589.
21. Keso L, Salaspuro M (1990c) Laboratory tests in the follow-up of treated alcoholics: how often should testing be repeated? Alcohol Alcohol 25:359-363.
22. Koch H, Meerkerk GJ, Zaat JO, Ham MF, Scholten RJ, Assendelft WJ (2004) Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review. Alcohol Alcohol 39:75-85.
23. Lemmens PH (1994) The alcohol content of self-report and 'standard' drinks. Addiction 89:593-601.
24. Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA (2000) Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin Exp Res 24:1873-1882.
25. Liu J, Lewohl JM, Dodd PR, Harris RA, Mayfield RD (2004) Gene expression profiling of individual cases reveals consistent transcriptional changes in alcoholic human brain. J Neurochem 90:1050-1058.
26. Mayfield RD, Lewohl JM, Dodd PR, Herlihy A, Liu J, Harris RA (2002) Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J Neurochem 81:802-813.
27. McNamara JR, Warnick GR, Leary ET, Wittels E, Nelson FE, Pearl MF, Schaefer EI (1996) Multicenter evaluation of a patient-administered test for blood cholesterol measurement. Prev Med 25:583-592.
28. Mimics K, Middleton FA, Marquez A, Lewis DA, Levitt P (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
29. Mor O, Nativ O, Stein A, Novak L, Lehavi D, Shiboleth Y, Rozen A, Berent E, Brodsky L, Feinstein E, Rahav A, Morag K, Rothenstein D, Persi N, Mor Y, Skaliter R, Regev A (2003) Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene 22:7702-7710.
30. Okutsu J, Tsunoda T, Kaneta Y, Katagiri T, Kitahara O, Zembutsu H, Yanagawa R, Miyawaki S, Kuriyama K, Kubota N, Kimura Y, Kubo K, Yagasaki F, Higa T, Taguchi H, Tobita T, Akiyama H, Takeshita A, Wang YH, Motoji T, Ohno R, Nakamura Y (2002) Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis. Mol Cancer Ther 1:1035-1042.
31. Orrego H, Blake JE, Blendis LM, Kapur BM, Israel Y (1979) Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 2:1354-1356.
32. Qiao Q, Keinanen-Kiukaanniemi S, Rajala U, Uusimaki A, Kivela SL (1995) Random capillary whole blood glucose test as a screening test for diabetes mellitus in a middle-aged population. Scand J Clin Lab Invest 55:3-8.
33. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 101:9309-9314.
34. Saito M, Smiley J, Toth R, Vadasz C (2002) Microarray analysis of gene expression in rat hippocampus after chronic ethanol treatment. Neurochem Res 27:1221-1229.
35. Salaspuro M (1999) Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol 19:261-271.
36. Scouller K, Conigrave KM, Macaskill P, Irwig L, Whitfield JB (2000) Should we use carbohydrate-deficient transferrin instead of gamma- glutamyltransferase for detecting problem drinkers? A systematic review and metaanalysis. Clin Chem 46:1894-1902.
37. Seino Y, Ogata K, Takano T, Ishii J, Hishida H, Morita H, Takeshita H, Takagi Y, Sugiyama H, Tanaka T, Kitaura Y (2003) Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 115:185-190.
38. Szegedi A, Anghelescu I, Pauly T, Dahmen N, Muller MJ, Wetzel H, Hiemke C (1998) Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependent. Alcohol Clin Exp Res 22:2073-2079.
39. Tabakoff B, Bhave SV, Hoffman PL (2003) Selective breeding, quantitative trait locus analysis, and gene arrays identify candidate genes for complex drug-related behaviors. J Neurosci 23:4491-4498.
40. Tang Y, Lu A, Aronow BJ, Sharp FR (2001) Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 50:699-707.
41. Taxman DJ, MacKeigan JP, Clements C, Bergstralh DT, Ting JP (2003) Transcriptional profiling of targets for combination therapy of lung carcinoma with paclitaxel and mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor. Cancer Res 63:5095-5104.
42. Thibault C, Lai C, Wilke N, Duong B, Olive MF, Rahman S, Dong H, Hodge CW, Lockhart DJ, Miles MF (2000) Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol 58:1593-1600.
43. Thorson SC, Mincey EK, McIntosh HW, Morrison RT (1972) Evaluation of a new in-vitro blood test for determining thyroid status: the effective thyroxine ratio. BMJ 2:67-71.
44. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798-805.
45. Traffic Safety Facts, (2000) U.S. Department of Transportation. National Highway Traffic Safety Administration. Available at: http://www.nhtsa. dot.gov. Accessed July, 2004.
46. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO (2003) Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100:1896-1901.
47. Xu Y, Ehringer M, Yang F, Sikela JM (2001) Comparison of global brain gene expression profiles between inbred long-sleep and inbred short-sleep mice by high-density gene array hybridization. Alcohol Clin Exp Res 25:810-818.